Pathologic Gambling: A Nonsubstance, Substance-Related Disorder?
The First Three Years of Buprenorphine in the United States: Experience to Date and Future Directions
Buprenorphine: The Basic Pharmacology Revisited
Clinical Case Discussion: Treating Opioid Dependence with Buprenorphine
No-Show for Treatment in Substance Abuse Patients with Comorbid Symptomatology: Validity Results from a Controlled Trial of the ASAM Patient Placement Criteria
Pharmacokinetics of Buprenorphine: A Comparison of Sublingual Tablet Versus Liquid after Chronic Dosing
Reduced Plasma Nitric Oxide End Products in Cocaine-dependent Men
Two-year Experience with Buprenorphine-naloxone (Suboxone) for Maintenance Treatment of Opioid Dependence Within a Private Practice Setting
Medication Groups for Office Based Opioid Treatment
A Call for Papers